Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden · Delayed Price · Currency is SEK 2.010
0.00 (0.00%)
Jun 16, 2026, 10:24 AM CET
STO:NEWBRY Market Cap
STO:NEWBRY has a market cap or net worth of 61.1 million as of June 15, 2026. Its market cap has decreased by -11.83% in one year.
Market Cap
61.10M
Enterprise Value
51.03M
Revenue
32.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.01
Market Cap Chart
Since February 4, 2022, STO:NEWBRY's market cap has decreased from 245.97M to 61.10M, a decrease of -75.16%. That is a compound annual growth rate of -27.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 56.54M | 61.74% |
| Dec 30, 2025 | 34.96M | -59.06% |
| Dec 30, 2024 | 85.39M | 42.48% |
| Dec 29, 2023 | 59.93M | -56.08% |
| Dec 30, 2022 | 136.45M | -44.52% |
| Feb 4, 2022 | 245.97M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 825.07M |
| EQL Pharma AB | 724.95M |
| Orexo AB | 722.88M |
| Enzymatica AB | 611.69M |
| Cinclus Pharma Holding AB | 565.90M |
| Dicot Pharma AB | 499.92M |
| Moberg Pharma AB | 474.71M |
| Klaria Pharma Holding AB (publ.) | 197.03M |